News

electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting

ROCKAWAY, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced…

1 year ago

Cidara Therapeutics to Present at Adenosine Pathway Targeted Cancer Immunotherapy Summit

SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed…

1 year ago

TELUS Health 2023 Drug Trends Report: Diabetes now the top drug category for claims; antidepressants surged for youth

Annual report indicates noticeable impact on prescription medications post-pandemic with clear link to declining mental health TELUS Health 2023 Drug…

1 year ago

X4 Pharmaceuticals Expected to Join Russell 3000® Index

BOSTON, June 13, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel…

1 year ago

Jin Medical International Ltd. Releases New-Generation Ultralight Portable Electric Wheelchairs and Electric Mobility Vehicles for the Elderly

Jin Medical International Ltd. Electric Mobility Vehicle "E-Scooter" Jin Medical International Ltd. Ultralight Portable Electric WheelchairChangzhou City, China, June 13,…

1 year ago

Press Release: Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients

  Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients Paris, June 13, 2023. Sanofi…

1 year ago

Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors

Planegg/Martinsried, June 13, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and…

1 year ago

Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer

CAMBRIDGE, Mass. and NEW YORK, June 13, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision…

1 year ago

Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for Narcolepsy

Among 100 clinicians, the primary driver of overall oxybate choice, potential to improve patient quality of life, and decrease stress/anxiety…

1 year ago